-
Functional Areas
- Audit and Investigations
-
Capacity development and transition, strengthening systems for health
- A Strategic Approach to Capacity Development
- Capacity Development and Transition - Lessons Learned
- Capacity development and Transition Planning Process
- Capacity Development and Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Functional Capacities
- Interim Principal Recipient of Global Fund Grants
- Legal and Policy Enabling Environment
- Overview
- Resilience and Sustainability
- Transition
-
Financial Management
- CCM Funding
- Grant Closure
- Grant Implementation
- Grant-Making and Signing
- Grant Reporting
- Overview
- Sub-recipient Management
-
Grant closure
- Overview
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
- Terminology and Scenarios for Grant Closure Process
- Human resources
- Human rights, key populations and gender
-
Legal Framework
- Agreements with Sub-sub-recipients
- Amending Legal Agreements
- Implementation Letters and Management Letters
- Language of the Grant Agreement and other Legal Instruments
- Legal Framework for Other UNDP Support Roles
- Other Legal and Implementation Considerations
- Overview
- Project Document
- Signing Legal Agreements and Requests for Disbursement
-
The Grant Agreement
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Conditions
- Grant Confirmation: Face Sheet
- Grant Confirmation: Limited Liability Clause
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation
- UNDP-Global Fund Grant Regulations
- Monitoring and Evaluation
- Principal Recipient Start-Up
-
Procurement and Supply Management
- Development of List of Health Products and Procurement Action Plan
- Distribution and Inventory Management
- Overview
- Price and Quality Reporting (PQR) System
- Procurement of Non-health Products and Services
- Procurement of Pharmaceutical and Other Health Products
- Quality Control
- Rational use of Medicines and Pharmacovigilance Systems
- Strengthening of PSM Services and Risk Mitigation
- UNDP Health PSM Roster
- UNDP Quality Assurance Policy and Plan
-
Reporting
- Communicating Results
- Grant Performance Report
- Overview
- Performance-based Funding and Disbursement Decision
- PR and Coordinating Mechanism (CM) Communication and Governance
- Reporting to the Global Fund
- UNDP Corporate Reporting
-
Risk Management
- Common Risks Identified in Global Fund Programmes
- Global Fund Risk Management
- Introduction to Risk Management
- Overview
- Risk Management in High Risk Environments
- Risk Management in UNDP-managed Global Fund Grants
- Risk management in UNDP
- UNDP Risk Management in the Global Fund Portfolio
- Sub-Recipient Management
Programmatic Sections of the Progress Update
The frequency of submission of programmatic updates to the Global Fund varies by country. For more information, please refer to the overview of the Global Fund’s differentiated approach and/or contact the Global Fund/Health Implementation Support Team.
The ‘Programme Progress’ section of the Progress Update includes Tab 1A: Impact/Outcome Indicators; 1B: Coverage Indicators and 1C: Work plan tracking measures. The results reported normally reflect activities carried out in the period just completed and should be inputted according to the most recent approved performance framework (PF). In some cases, however, it may not be possible to receive information before the 45-day window for reporting to the Global Fund elapses. If this is unavoidable, the Principal Recipient (PR) should still submit the report for that period, but the results for that particular indicator will relate to the preceding period and not to the period just completed.
In the ‘Reasons for Programmatic Deviation’ box, the PR should attempt to fully explain all valid reasons for under- or over-achievement of targets. Examples of common reasons for underachievement include: delays in disbursement or procurement, Sub-recipients (SRs) not contracted in the time originally planned or sub-optimal functionality, challenges in robust and reliable data collection, or the indicator is not measurable as written.[1]
Following the submission of the semi-annual Progress Update or the annual Progress Update/Disbursement Request (PU/DR), the Global Fund issues a Management Letter (ML), which provides feedback and recommendations for the PR on the implementation of the programme. The PR should respond in writing to the Global Fund addressing the issues raised in the ML, by the deadline specified in the ML or no later than two weeks following receipt of the ML.
It is strongly recommended that Country Offices (COs) share the draft reply to the Global Fund’s Management Letter with Sub-recipients (where applicable) for feedback as well as with the Global Fund/Health Implementation Support Team Programme Advisors to obtain feedback and comments in advance of sending the final response to the Global Fund.
In Grant Management (Tab 4), all conditions precedent (CP) and special conditions (SCs) contained in the Grant Agreement/Grant Confirmation or management actions in any subsequent implementation letters that are due for reporting during the period covered by the Progress Update should be listed. The PR must provide a status update on all listed CP and special conditions SCs. In addition, all management actions assigned to the PR by the Global Fund that are outstanding should be listed with a reference to the date of the respective Performance Letter and action number. Comments on progress toward fulfilment should be provided for each management action.
In PR’s Overall Self Evaluation of grant performance (Tab 5), the PR should include self-evaluation of grant performance to date, undertaken by taking into account programmatic achievements, financial performance and programme issues in various functional areas (M&E, finance, procurement and programme management, including management of SRs); a description of external contextual factors that have had or may have an impact on programme performance; a description of any planned changes to the programme.
Features of the Revised January 2016 PU/DR template
Please note the following features of the programmatic and procurement sections of the revised January 2016 PU/DR template (reporting required where relevant based on Global Fund approved Performance Framework):
- Reporting on progress achieved against workplan tracking measures where applicable;
- Reporting disaggregated results for select Impact/Outcome and Coverage Indicators where applicable. For a list of indicators requiring disaggregation, please refer to Annex 1 of the Global Fund Progress Update/Disbursement Request Guidelines;
- Indicators can now be selected from dropdown lists. It is important to ensure correct information (disease component, PU or PUDR) is checked on PUDR cover sheet; and
- Procurement and Supply Management – PRs are expected to respond to the questions on risks of stock-out and expiry by referring to the most recent stock status report available at the country level at the time of completing their PU or PU/DR.
[1] If during programme implementation the PR observes that a target set or an indicator agreed to in the PF is no longer applicable/achievable, due to a changing epidemiological landscape or reasons beyond the control of the PR, this should be brought to the attention of the FPM and a request to amend the PF through an Implementation Letter should be considered.